439 related articles for article (PubMed ID: 12902859)
1. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
Milas L
Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
3. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
Liao Z; Milas L; Komaki R; Stevens C; Cox JD
Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
[TBL] [Abstract][Full Text] [Related]
4. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
[TBL] [Abstract][Full Text] [Related]
5. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse.
Milas L
Semin Radiat Oncol; 2001 Oct; 11(4):290-9. PubMed ID: 11677654
[TBL] [Abstract][Full Text] [Related]
7. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
Stańczyk J; Kowalski ML
Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
[TBL] [Abstract][Full Text] [Related]
8. Is cyclooxygenase-2 important in skin carcinogenesis?
Fischer SM
J Environ Pathol Toxicol Oncol; 2002; 21(2):183-91. PubMed ID: 12086405
[TBL] [Abstract][Full Text] [Related]
9. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Liao Z; Milas L
Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
11. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235
[TBL] [Abstract][Full Text] [Related]
13. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
14. Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
Milas L; Mason KA; Crane CH; Liao Z; Masferrer J
Oncology (Williston Park); 2003 May; 17(5 Suppl 5):15-24. PubMed ID: 12800601
[TBL] [Abstract][Full Text] [Related]
15. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
16. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
Kundu N; Fulton AM
Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
[TBL] [Abstract][Full Text] [Related]
17. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
Ohara M; Sawa T
Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
[TBL] [Abstract][Full Text] [Related]
18. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
20. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]